Telo Genomics Corp (TSE:TELO) has released an update.
Telo Genomics Corp. has successfully completed an over-subscribed private placement, raising $650,000 through the sale of 3.25 million units at $0.20 each. Each unit includes a share and a half-warrant, with full warrants allowing the purchase of an additional share at $0.40 until 2027. The funds raised are earmarked for general working capital, while the securities are subject to a hold period and TSX Venture Exchange final approval.
For further insights into TSE:TELO stock, check out TipRanks’ Stock Analysis page.
